Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

... > Nucleic Acids, Nucleotides, and Nucleosides > Nucleotides > Ribonucleotides > Uracil Nucleotides > Uridine Monophosphate > Sofosbuvir
... > Carbohydrates > Glycosides > Nucleotides > Ribonucleotides > Uracil Nucleotides > Uridine Monophosphate > Sofosbuvir
... > Heterocyclic Compounds > Heterocyclic Compounds, 1-Ring > Pyrimidines > Pyrimidine Nucleotides > Uracil Nucleotides > Uridine Monophosphate > Sofosbuvir
... > Nucleic Acids, Nucleotides, and Nucleosides > Nucleotides > Pyrimidine Nucleotides > Uracil Nucleotides > Uridine Monophosphate > Sofosbuvir
... > Carbohydrates > Glycosides > Nucleotides > Pyrimidine Nucleotides > Uracil Nucleotides > Uridine Monophosphate > Sofosbuvir

Preferred term

Sofosbuvir  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • 2-((5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy)phenoxyphosphorylamino)propionic acid isopropyl ester

Scope note

  • A uridine monophosphate analog inhibitor of HEPATITIS C VIRUS (HCV) polymerase NS5B that is used as an ANTIVIRAL AGENT in the treatment of CHRONIC HEPATITIS C.

History note

  • 2016 (2010)

In other languages

URI

http://www.yso.fi/onto/mesh/D000069474

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/1/15, last modified 5/31/16